JNJ Johnson & Johnson | US4781601046
| Metric | Current | 30.06.2026 | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|---|
| Market Cap | 634.767.278.080 | 611.617.668.099,73 | 588.265.643.275,45 | 498.322.968.701,55 | 446.156.672.494,13 |
| Enterprise Value | 663.045.275.648 | 640.231.668.099,73 | 621.564.643.275,45 | 526.546.968.701,55 | 473.720.672.494,13 |
| Trailing P/E | 30,59 | 29,07 | 27,96 | 31,53 | 41,74 |
| Forward P/E | 20,53 | - | - | - | - |
| Price to Sales | 6,48 | 6,25 | 6,1 | 6,89 | 9,35 |
| Price to Book | 7,81 | 7,2 | 7,25 | 6,11 | 5,63 |
| EV/Revenue | 6,77 | 6,54 | 6,45 | 7,28 | 9,92 |
| EV/EBITDA | 19,01 | 18,3 | 17,87 | 20,22 | 26,2 |